TransMedics (TMDX) Other financing activities (2019 - 2025)

TransMedics (TMDX) recorded quarterly Other financing activities of $138000.0 in Q3 2025, down 62.3% quarter-over-quarter from $366000.0 in Q3 2020.

TransMedics (TMDX) Other financing activities (2019 - 2025) Analysis & Trends

TransMedics' Other financing activities history runs 3 years deep, the most recent figure standing at $138000.0 for Q3 2025.

In Q3 2025, Other financing activities changed N/A year-over-year to $138000.0; the TTM figure through Sep 2025 stood at $723000.0 (changed N/A YoY), while the FY2020 annual figure was $705000.0, down 85.45% from the prior year.
Other financing activities was $138000.0 for Q3 2025 at TransMedics, down from $366000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $138000.0 in Q3 2025 to a low of $138000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	TransMedics	2.72 Bn	2.26 Bn	101.16 Mn

Download Data